RBC Capital Starts Five Prime Therapeutics (FPRX) at Outperform
Tweet
Share
E-mailGet Alerts FPRX Hot Sheet
Price: $38.00 --0%
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 46 | New: 42
Rating Summary:
9 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 46 | New: 42
Join SI Premium – FREE
RBC Capital initiates coverage on Five Prime Therapeutics (NASDAQ: FPRX) with a Outperform rating and a price target of $41.00.
For an analyst ratings summary and ratings history on Five Prime Therapeutics click here. For more ratings news on Five Prime Therapeutics click here.
Shares of Five Prime Therapeutics closed at $35.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts RENK Group AG (R3NK:GR) at Overweight
- Barclays Starts Kongsberg Gruppen ASA (KOG:NO) at Overweight
- BofA Securities Reinstates Woodside Energy Group Ltd (WDS:AU) (WDS) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
